 |
|
Stem cell transplantation procedure results in long-term survival for amyloidosis patients
August 08, 2007(Boston) - Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain (AL) Amyloidosis.
The findings appear prepublished in the First Edition of Blood and can be viewed on Blood Online at http://www.bloodjournal.org/papbyrecent.shtml. BUMC was the first to begin using this treatment in 1994 and is the only center to publish these long-term outcome results.
AL amyloidosis occurs when plasma cells in bone marrow produce proteins that misfold and deposit in tissues, leading to organ failure and death. Between 1,200 and 3,200 new cases are reported each year in the United States, although researchers believe the disease is highly underdiagnosed.
The researchers reviewed the records of 80 patients who received high-dose chemotherapy and blood stem cell transplantation from July 1994 through July 1997. The median survival for all 80 patients was 57 months. Eighteen of these patients, (23 percent) are still alive today, 10 or more years after undergoing the treatment. By comparison, only two percent of patients treated with oral melphalan and prednisone have survived more than 10 years.
According to lead researcher, Vaishali Sanchorawala, MD, an associate professor of medicine at Boston University School of Medicine, and clinical director of the Stem Cell Transplant Program, section of hematology/oncology at BUMC, high-dose intravenous melphalan and autologous stem cell transplantation has become a first-line treatment for patients with AL amyloidosis. "However, efforts need to continue to be directed upon achieving a complete hematologic response in patients," she says. "We are finding that the proportion of patients who ultimately achieve a complete response have the highest rate of long-term survival," she adds.
Boston University
The researchers reviewed the records of 80 patients who received high-dose chemotherapy and blood stem cell transplantation from July 1994 through July 1997. The median survival for all 80 patients was 57 months. Eighteen of these patients, (23 percent) are still alive today, 10 or more years after undergoing the treatment. By comparison, only two percent of patients treated with oral melphalan and prednisone have survived more than 10 years.
According to lead researcher, Vaishali Sanchorawala, MD, an associate professor of medicine at Boston University School of Medicine, and clinical director of the Stem Cell Transplant Program, section of hematology/oncology at BUMC, high-dose intravenous melphalan and autologous stem cell transplantation has become a first-line treatment for patients with AL amyloidosis. "However, efforts need to continue to be directed upon achieving a complete hematologic response in patients," she says. "We are finding that the proportion of patients who ultimately achieve a complete response have the highest rate of long-term survival," she adds.
Boston University
Stem Cell Transplantation Current Events and Stem Cell Transplantation News RSSGene mismatch influences success of bone marrow transplants
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.
U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.
Immunotherapy demonstrates long-term success in treating lymphoma
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).
Rare genetic disease successfully reversed using stem cell transplantation
A recent study by Scripps Research Institute scientists offers good news for families of children afflicted with the rare genetic disorder, cystinosis.
Trimming the fat boosts blood recovery after marrow transplant
Seeking ways to improve blood recovery after chemotherapy or bone marrow transplant, researchers at Children's Hospital Boston have discovered that fat cells, which accumulate in bone marrow as people age, inhibit the marrow's ability to produce new blood cells.
Stem cell protein offers a new cancer target
A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.
New therapy enlists immune system to boost cure rate in a childhood cancer
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.
What do blood stem cells need to grow? Blood flow
Blood stem cells literally go with the flow, according to a new report published as an immediate early publication in the journal Cell, a Cell Press journal, on May 13th.
Embryo's heartbeat drives blood stem cell formation
Biologists have long wondered why the embryonic heart begins beating so early, before the tissues actually need to be infused with blood.
Multiple route bone marrow stem cell injections show promise to treat spinal cord injury
Researchers from DaVinci Biosciences, Costa Mesa, California, in collaboration with Hospital Luis Vernaza in Ecuador, have determined that injecting a patient's own bone marrow-derived stem cells (autologous BMCs) directly into the spinal column using multiple routes can be an effective treatment for spinal cord injury (SCI) that returns some quality of life for SCI patients without serious adverse events.
More Stem Cell Transplantation Current Events and Stem Cell Transplantation News Articles
 |
Manual of Stem Cell and Bone Marrow Transplantation (Cambridge Medicine) by Joseph H. Antin MD (Author), Deborah S. Yolin (Author) Over the past 35 years, stem cell and bone marrow transplantation have evolved from experimental therapies to well-established and widely used treatments for a variety of malignant and nonmalignant conditions. This is a practical pocket manual for all members of the stem cell and bone marrow transplant team, based on a popular in-house handbook used at the Dana-Farber Cancer Institute. The manual covers all aspects of the transplantation process, from stem cell processing through management of transplant-related complications. Evaluation and counseling of patients and donors, preventative care, and conditioning regimens are also covered, making this an ideal resource for nurses as well. The text is handily arranged in outline format to maximize the usefulness and convenience of this... |
 |
Hematopoietic Stem Cell Transplantation in Clinical Practice by Jennifer G. Treleaven MD FRCP FRCPath (Author), A. John Barrett MD FRCP FRCPath (Author) A guide to the practice of stem cell transplantation, its status in the treatment of various disorders and the problems that arise after transplantation, aimed at the whole transplant team. An up to date guide to best practice in the use of stem cell transplantation, covering current status in the treatment of malignant and non-malignant conditions, practical aspects and problems such as infection and graft versus host disease.Has a practical, accessible approach with free use of algorithms, list tables.Aimed at the whole transplant team - this is an interdisciplinary field.International contributor team with editors in the UK and USA.Illustrated in colour throughout. |
 |
Can We Cure the Common Leukemias? |
 |
Hematopoietic Stem Cell Transplantation (Contemporary Hematology) by Robert J. Soiffer (Editor) Remarkable developments in the field of transplantation have created opportunities to address the formidable challenges of transplantation across histocompatibility barriers, stem cell expansion, and prevention of complications and generation of graft-vs-tumor activity to eradicate residual disease. Stem Cell Transplantation for Hematologic and Other Disorders, Second Edition provides a glimpse into potential future applications of bone marrow derived stem cells in the field of cardiac repair. The updated chapters introduce the biologic underpinnings of hematopoietic cell transplantation, basic stem cell biology, immunobiology, and histocompatibility, with emphasis on indications and results of transplantation for specific diseases. Written by experts in the field, Stem Cell... |
 |
Practical Hematopoietic Stem Cell Transplantation by Andrew J. Cant (Editor), Angela Galloway (Editor), Graham Jackson (Editor) Practical Hematopoietic Stem Cell Transplantation is the only comprehensive yet practical guide to the total care of the transplant patient. It provides a ready source of reference to help health care professionals involved in the management of patients requiring bone marrow and stem cell transplantations – covering many of the infections and complications that may arise. An essential, practical manual for all those working in the field of bone marrow and stem cell transplantation Whether you are an established... |
 |
Blood And Marrow Stem Cell Transplantation: Principles, Practice, And Nursing Insights by Susan Ezzone (Author), Kim Schmit-pokorny (Editor) Blood and Marrow Stem Cell Transplantation, Third Edition serves as a convenient reference for oncology nurses caring for blood and marrow stem cell transplantation recipients. The Third Edition has been updated and revised to reflect the most current research related to the past, present, and future of blood and marrow stem cell transplants. This resource covers everything from preparing for transplantation, to recovery-related issues and delayed outcomes. Basic background information on transplantation procedures and processes are provided, along with in-depth coverage of pulmonary, cardiac, renal and hepatic, neurologic, and hematologic effects. A chapter devoted to controversial ethical issues is also provided. Blood and Marrow Stem Cell Transplantation, Third Edition... |
 |
100 Questions & Answers About Bone Marrow and Stem Cell Transplantation by Ewa Carrier (Author), Gracy Ledingham (Author) For people fighting many kinds of disease, bone marrow transplantation or stem cell transplantation may be the only realistic chance of a cure -- but the procedure is complicated and frightening, with many long-term ramifications. How do you decide whether this method of treatment is for you? Along with your physician's advice, let 100 Questions and Answers About Bone Marrow and Stem Cell Transplantation be your guide. It is the only book that offers the first-hand experiences of a patient and the perspective of a transplant doctor to provide you with authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. This book is an invaluable resource for anyone considering a bone marrow or stem cell... |
 |
Blood and Marrow Transplantation: A Patient's Guide to Hematopoietic Stem Cell Transplantation by Fairview Health Services (Author) This one-of-a-kind guide helps inform donors, transplant recipients, and their loved ones of what to expect from the procedure. |
 |
Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians by American Association of Blood Banks (AABB) (Author), John R. Wingard (Editor), MD (Editor), Dennis A. Gastineau (Editor), Helen L. Leather (Editor), BPharm (Editor), Edwards Snyder (Editor), MD FACP (Editor), Zbigniew M. Szczepiorkowski (Editor), MD PhD (Editor), FCAP (Editor) Chapters in this easy-to-use guide reflect the combined expertise of practitioners from the Dana-Farber, M.D. Anderson, Memorial Sloan-Kettering, Fred Hutchinson, and other notable cancer centers; from the National Cancer Institute and NMDP; and from numerous respected university programs and medical institutions. The aim of this HSCT Handbook is to broadly cover the major topics of indications for transplantation; donor and patient evaluation; conditioning regimens; collection, processing, and characterization of stem cell products; management of immunosuppressive therapy; evaluation and management of the myriad complications encountered; suggestions for supportive care; performance of the most common procedures; and aspects of follow-up care. The Handbook s emphasis is on... |
 |
Allogeneic Stem Cell Transplantation (Contemporary Hematology) by Hillard Lazarus (Editor), Mary Laughlin (Editor) Since the original publication of Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Allogeneic hematopoietic stem cell transplantation (HSC) has undergone several fast-paced changes. In this second edition, the editors have focused on topics relevant to evolving knowledge in the field in order to better guide clinicians in decision-making and management of their patients, as well as help lead laboratory investigators in new directions emanating from clinical observations. Some of the most respected clinicians and scientists in this discipline have responded to the recent advances in the field by providing state-of-the-art discussions addressing these topics in the second edition. The text covers the scope of human genomic variation, the methods of HLA typing and... |
| © 2009 BrightSurf.com |